Research Papers: Gerotarget (Focus on Aging):

MeCP2 mediated dysfunction in senescent EPCs

Chunli Wang, Fei Wang, Zhen Li, Liya Huang, Qing Cao and Shuyan Chen _

PDF  |  HTML  |  How to cite

Oncotarget. 2017; 8:78289-78299. https://doi.org/10.18632/oncotarget.20961

Metrics: PDF 1571 views  |   HTML 2490 views  |   ?  


Chunli Wang1,*, Fei Wang1,*, Zhen Li1, Liya Huang1, Qing Cao1 and Shuyan Chen1

1 Department of Geriatrics, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China

* These authors have contributed equally to this work

Correspondence to:

Shuyan Chen, email:

Keywords: EPCs, senescence, MeCP2, SIRT1, Gerotarget

Received: April 20, 2017 Accepted: August 26, 2017 Published: September 16, 2017


Aging endothelial progenitor cells (EPCs) exhibit functional impairment in terms of proliferation, migration and survival. SIRT1 plays an important role in improving EPCs function. MeCP2, another important epigenetic regulator, is involved in regulating many life-related activities such as cell growth, death and senescence. Here we aim to explore the effect of MeCP2 on the functional activities of senescent EPCs and the underlying mechanisms. By using western blot and real-time PCR, we found that the expression levels of MeCP2 were up-regulated and SIRT1 were down-regulated with replicative senescence and H2O2-induced senescence. Through transduction with adenoviral vectors, EPCs overexpressing MeCP2 had significantly reduced EPCs function, and silencing MeCP2 improved EPCs function. In addition, the protein and mRNA levels of SIRT1 were decreased with MeCP2 overexpression and increased with MeCP2 knockdown. Through co-transfection of EPCs with MeCP2 and SIRT1, we observed that SIRT1 could reverse the effects of MeCP2 on EPCs. In summary, our work demonstrated that MeCP2 inhibited SIRT1 in senescent EPCs.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 20961